| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |